8.1 Who May Prescribe in Connecticut
Key Takeaways
- CGS § 20-14c defines a Connecticut prescribing practitioner as a physician, dentist, podiatrist, optometrist, physician assistant, APRN, nurse-midwife, or veterinarian licensed by Connecticut and authorized to prescribe within that person's scope.
- For filling, CGS § 20-571 uses a broader definition: a prescriber licensed in Connecticut, any other U.S. state, D.C., Puerto Rico, or a U.S. territory who is authorized to issue the prescription within that individual's practice.
- APRN independence requires three years and at least 2,000 collaborative hours (CGS § 20-87a); PAs never practice independently and need a written delegation agreement (CGS § 20-12d). Schedule II–III PA orders require documented supervising-physician approval in the chart.
- Since 2018 (CGS § 21a-252(j)–(k)), a prescriber may not issue Schedule II–IV controlled substances to self or an immediate family member except a 72-hour emergency supply when no other qualified prescriber is available.
- A practitioner who will prescribe controlled substances in Connecticut needs a federal DEA registration and a Connecticut controlled-substance practitioner (CSP) registration under Chapter 420c (CGS § 21a-317), plus CPMRS access.
Why prescriber identity is an MPJE item
Quick Answer: A prescription is a lawful order from a prescribing practitioner for a specific patient (CGS § 20-571). CGS § 20-14c names the Connecticut license types. CGS § 20-571 is the filling definition and includes out-of-state U.S. licensees. Scope is always in play: an optometrist does not treat pneumonia; a veterinarian does not treat a human. Controlled substances add DEA + Connecticut CSP (CGS § 21a-317). APRN independence is earned (3 years + 2,000 hours). PAs never practice independently. Self- and family-prescribing of Schedule II–IV drugs is banned except a 72-hour emergency (CGS § 21a-252(j)–(k)).
NABP Competency 2.1.2 tests whether the writer is legally able to issue the order that just printed. Connecticut answers with two definitions, a scope overlay, a collaboration/supervision overlay, and a controlled-substance registration overlay. Mixing those four is how candidates fill an invalid order or refuse a valid one.
CGS § 20-14c(3) (the definition used in many Drug Control statutes, including the EPCS mandate in § 21a-249(b)) means a physician, dentist, podiatrist, optometrist, physician assistant, advanced practice registered nurse, nurse-midwife, or veterinarian licensed by the state of Connecticut and authorized to prescribe within the scope of that person's practice. Osteopathic physicians are physicians; Connecticut deleted a separate osteopathy category in P.A. 99-102.
CGS § 20-571, the Pharmacy Practice Act definition used when a pharmacy sells and dispenses, is broader: an individual licensed by Connecticut, any other U.S. state, the District of Columbia, Puerto Rico, or any U.S. territory or insular possession, who is authorized to issue a prescription within the scope of the individual's practice. CGS § 21a-249(j) then lets a pharmacy dispense controlled substances on a prescription of a § 20-571 prescribing practitioner. That is the statutory hook for out-of-state fills.
Independent versus collaborative or supervisory authority
| Practitioner | Practice relationship | Noncontrolled authority | Controlled-substance authority (plus DEA and, if prescribing in Connecticut, CSP) |
|---|---|---|---|
| Physician (MD/DO) | Independent | Full medical scope | CII–V in good faith in the course of professional practice (CGS § 21a-252(a)); not for drug dependence except as federal and state treatment rules allow |
| Dentist | Independent within dentistry | Dental scope | CII–V to the extent dentistry and federal CSA allow (CGS § 21a-252(b)) |
| Podiatrist | Independent within podiatry | Podiatric scope | CII–V within podiatry (CGS § 21a-252(c)) |
| Optometrist (advanced optometric care) | Independent within the eye and ocular adnexae | Ocular diagnostics and therapeutics under CGS § 20-127 | CII–V to the extent of optometry (CGS § 21a-252(h)); office dispensing of those CS is generally a 72-hour supply with no charge unless the smallest pack is larger (CGS § 20-127(f)) |
| Veterinarian | Independent for animals | Veterinary; Rx names the owner and the species | CII–V not for use by a human being (CGS § 21a-252(d)) |
| APRN — first 3 years | Must collaborate with a Connecticut-licensed physician; the prescriptive collaboration must be in writing and must address the level of Schedule II and III drugs the APRN may prescribe (CGS § 20-87a(b)(2)) | Yes, under that collaboration | CII–V (CGS § 21a-252(e)), limited by the written CII/III level |
| APRN — after 3 years and ≥2,000 collaborative hours | May practice alone after written notice to the Commissioner of Public Health; DPH publishes an annual list (CGS § 20-87a(b)(3)) | Yes | CII–V without a collaborating physician |
| Physician assistant | Never independent (CGS § 20-12d(c)); written delegation agreement with a supervising physician, reviewed at least annually | Legend drugs as delegated, within the supervising physician's license and actual practice | CIV–V prescribe and administer in all settings; CII–III prescribe and administer if the supervising physician documents approval in the patient's medical record in the manner the agreement prescribes; may renew CII–V (CGS § 20-12d(a)) |
| Nurse-midwife (CNM) | Practices within a health care system or birth center and must have clinical relationships with obstetrician-gynecologists for consultation, collaborative management, or referral (CGS § 20-86b) | Midwifery scope | CII–V (CGS § 21a-252(f)) |
CRNAs are APRNs. A CRNA who is prescribing and administering medical therapeutics during surgery may do so only if the physician medically directing that activity is physically present in the institution, clinic, or other setting where the surgery is performed (CGS § 20-87a(b)(2)). That is a presence rule at the surgical site, not a pharmacy co-signature rule.
PA prescription forms must contain the PA's signature, name, address, and license number (CGS § 20-12d(b)). Written orders are followed by the PA's signature and printed name. P.A. 14-231 removed the requirement that the supervising physician's name appear on the PA's prescription form. The CII/III approval lives in the medical record under the delegation agreement; it is not a second signature the pharmacy is guaranteed to see. Corresponding responsibility still applies (Chapter 12).
Pharmacists do not independently issue prescriptions as prescribing practitioners under § 20-14c. Immunization, CDTM, naloxone, and contraception protocols are Chapter 10 authorities, not a general license to write hydrocodone.
Out-of-state prescribers at a Connecticut pharmacy
A New York internist, a Rhode Island dentist, or a Massachusetts APRN is a § 20-571 prescribing practitioner if that person is licensed there and the order is within that person's practice. DCP's current EPCS FAQ (updated April 2025) states that pharmacists may dispense a controlled substance pursuant to an out-of-state written or electronic prescription provided the prescription meets all of the requirements, state and federal, for issuing a prescription, and that it is the pharmacist's responsibility to determine validity using professional judgment.
Hold those two ideas together:
- The EPCS mandate in CGS § 21a-249(b) binds each § 20-14c practitioner whom DCP authorizes to prescribe controlled substances — that is, Connecticut-licensed, CSP-authorized writers. It is not a standing order that every out-of-state paper CII is automatically void.
- Filling still requires a valid prescription: genuine, in-scope, for a legitimate medical purpose, with the federal and applicable state issuance elements. An out-of-state CII that is missing a DEA number, is written by a hygienist, or is for a Connecticut human from a veterinarian is still unfillable.
A Connecticut CSP is required of practitioners who prescribe within this state (CGS § 21a-317). An out-of-state physician who never practices in Connecticut typically will not hold a CSP. Do not refuse solely for lack of a Connecticut CSP. Do refuse if you cannot authenticate the license, the DEA number, or the medical purpose.
Self-prescribing, family, and telehealth controlled substances
CGS § 21a-252(j) and (k) (P.A. 18-166 / P.A. 18-168; DCP's April 2025 prescribing-practice page flags 2018) bar a prescribing practitioner from prescribing, dispensing, or administering Schedule II, III, or IV controlled substances to an immediate family member or for the practitioner's own use, except in an emergency. In an emergency the supply is not more than 72 hours, and only when no other qualified prescribing practitioner is available. Immediate family means spouse, parent, child, sibling, parent-in-law, son- or daughter-in-law, brother- or sister-in-law, step-parent, step-child, step-sibling, or other relative residing in the same residence. It does not include an animal in the residence. The emergency still requires an assessment, a medical-need evaluation, and documentation of the emergency. Schedule V is outside this particular ban; it is not a free pass around corresponding responsibility or workplace policy.
Telehealth. CGS § 19a-906(c), as amended by P.A. 25-168 (effective June 30, 2025), still says no telehealth provider shall prescribe any Schedule I, II, or III controlled substance through telehealth, except a Schedule II or III substance used (1) as part of medication-assisted treatment, or (2) for the treatment of persons with psychiatric disabilities or substance use disorders (as defined in CGS § 17a-458), fully consistent with the Ryan Haight Act, 21 U.S.C. § 829(e). Those allowed CII/III telehealth prescriptions must be electronically submitted under § 21a-249. DCP's 2018 highlight — telehealth CII/III expanded in certain circumstances — is this exception, not a general CII telehealth license. Schedule IV and V are not banned by subsection (c), but DEA, CSP, EPCS, and Ryan Haight still apply. When federal DEA telemedicine flexibilities and Connecticut § 19a-906 differ, Connecticut may be stricter; more-restrictive wins.
Dual registration: DEA and CSP
CGS § 21a-317 (Chapter 420c) requires every practitioner who distributes, administers, or dispenses a controlled substance, or who proposes to prescribe one within this state, to (1) obtain a certificate of registration from the Commissioner of Consumer Protection (the CSP), and (2) register for CPMRS access. Federal DEA registration is separate. A new Connecticut prescriber who appears in the queue with a shiny DEA number and no CSP is not finished. Check elicense.ct.gov for the Connecticut professional license and CSP, and the DEA number on the controlled-substance order. Scope still caps the drug: an optometrist's oxycodone for back pain is the wrong organ system even if both numbers print.
Realistic Connecticut scenarios
A New Haven PA sends hydrocodone/acetaminophen 10/325, #20. The PA is Connecticut-licensed, DEA-registered, and CSP-registered; the supervising internist is on the delegation agreement. The pharmacy may fill if the order is otherwise valid. The statute does not require the internist's wet signature on the prescription. Corresponding responsibility still asks whether the quantity, diagnosis, and CPMRS story make sense.
A first-year APRN in Bridgeport has no written collaboration addressing Schedule II. A CII opioid is not a fill-and-hope situation. CGS § 20-87a(b)(2) requires that written CII/III level during the collaborative period.
A Hartford internist electronically sends a 30-day oxycodone supply to her spouse after a skiing fracture, documenting it as a convenience. That is § 21a-252(j), not an emergency, and not a 72-hour cap. Do not fill.
A Massachusetts family physician, licensed and DEA-registered in Massachusetts, sends an electronic lisinopril order — and separately a written out-of-state clonazepam — to a Stamford pharmacy for a patient who lives in Greenwich. § 20-571 reaches both. The clonazepam still needs federal CS elements and a pharmacist's validity judgment under DCP's out-of-state FAQ.
Official anchors
- CGS § 20-14c — Connecticut prescribing-practitioner definition.
- CGS § 20-12d — PA delegation and CS prescribing.
- CGS § 20-87a — APRN collaboration then independence.
- CGS § 21a-252 — who may prescribe CS; self/family 72-hour emergency.
- DCP prescribing-practice page (April 28, 2025) — 2018 self/family ban and telehealth CII/III expansion.
A Connecticut APRN licensed 18 months ago wants to prescribe oxycodone 5 mg for an adult outpatient. Which statement matches CGS § 20-87a and § 21a-252?
A Connecticut internist wants to send a 30-day alprazolam (Schedule IV) prescription to her adult child who lives in the same house, with no emergency and other prescribers available. Under CGS § 21a-252, what is allowed?
A Massachusetts-licensed physician, DEA-registered in Massachusetts, electronically sends a valid lisinopril prescription and a valid written clonazepam prescription to a Connecticut community pharmacy. The physician has no Connecticut CSP. Which statement matches CGS § 20-571 and current DCP guidance?